                               SEQUENCE LISTING

<110> BICYCLETX LIMITED
 
<120> PEPTIDE LIGANDS FOR BINDING TO CD38

<130> P6175PC00

<140> PCT/EP2019/066066
<141> 2019-06-18

<150> GB 1810320.0
<151> 2018-06-22

<160> 286   

<170> PatentIn version 3.5

<210> 1
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 1
Cys Phe Glu Leu Asp Gly Thr Cys Phe Asp Trp Ala Gln Glu Cys 
1               5                   10                  15  


<210> 2
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 2
Cys Val Asn Phe Gly Ser Val Cys Trp Asp Pro Asp Ser Arg Cys 
1               5                   10                  15  


<210> 3
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 3
Cys Val Pro Cys Ala Asp Phe Pro Ile Trp Tyr Cys 
1               5                   10          


<210> 4
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 4
Cys Val Pro Cys Ala Asp Phe Pro Ile Trp Trp Cys 
1               5                   10          


<210> 5
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 5
Cys Val Pro Cys Ala Asp Phe Pro Ile Trp Tyr Cys 
1               5                   10          


<210> 6
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 6
Cys Val Pro Cys Ala Asp Phe Pro Ile Trp Tyr Cys 
1               5                   10          


<210> 7
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 7
Cys Val Pro Cys Ala Asp Phe Pro Ile Trp Tyr Cys 
1               5                   10          


<210> 8
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 8
Cys Val Pro Cys Ala Asp Phe Pro Ile Trp Tyr Cys 
1               5                   10          


<210> 9
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 9
Cys Thr Pro Cys Ala Asp Phe Pro Ile Trp Ser Cys 
1               5                   10          


<210> 10
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 10
Cys Thr Pro Cys Ala Asp Phe Pro Ile His Thr Cys 
1               5                   10          


<210> 11
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 11
Cys Val His Cys Ala Asp Phe Pro Ile Trp Gly Cys 
1               5                   10          


<210> 12
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 12
Cys Val Pro Cys Ala Asp Phe Pro Ile Trp Gly Cys 
1               5                   10          


<210> 13
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 13
Cys Val Pro Cys Ala Asp Phe Pro Ile Trp Gly Cys 
1               5                   10          


<210> 14
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 14
Cys Val Met Cys Ala Asp Phe Pro Ile Trp Gly Cys 
1               5                   10          


<210> 15
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 15
Cys Thr Pro Cys Ala Asp Phe Pro Ile Trp Tyr Cys 
1               5                   10          


<210> 16
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 16
Cys Thr Pro Cys Ala Asp Phe Pro Ile Trp Tyr Cys 
1               5                   10          


<210> 17
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 17
Cys Thr Pro Cys Ala Asp Phe Pro Ile Leu Thr Cys 
1               5                   10          


<210> 18
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 18
Cys Val Ala Cys Ala Asp Phe Pro Ile Trp Gly Cys 
1               5                   10          


<210> 19
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 19
Cys Thr Pro Cys Ala Asp Phe Pro Ile Tyr Gly Cys 
1               5                   10          


<210> 20
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 20
Cys Thr Pro Cys Ala Asp Phe Pro Ile Leu Asp Cys 
1               5                   10          


<210> 21
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 21
Cys Val Lys Cys Ala Asp Phe Pro Ile Trp Gly Cys 
1               5                   10          


<210> 22
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 22
Cys Val Lys Cys Ala Asp Phe Pro Ile Trp Gly Cys 
1               5                   10          


<210> 23
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 23
Cys Thr Pro Cys Ala Asp Met Pro Ile Trp Thr Cys 
1               5                   10          


<210> 24
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 24
Cys Ile Pro Cys Ala Asp Phe Pro Ile Trp Gly Cys 
1               5                   10          


<210> 25
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 25
Cys Ile Pro Cys Ala Asp Phe Pro Ile Ser Val Cys 
1               5                   10          


<210> 26
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 26
Cys Val Pro Cys Ala Asp Phe Pro Ile Ser Phe Cys 
1               5                   10          


<210> 27
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 27
Cys Ile Pro Cys Ala Asp Phe Pro Ile Ser Phe Cys 
1               5                   10          


<210> 28
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 28
Cys Val Pro Cys Ala Asp Phe Pro Ile Ser Val Cys 
1               5                   10          


<210> 29
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 29
Cys Val Pro Cys Ala Asp Phe Pro Ile Phe Thr Cys 
1               5                   10          


<210> 30
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 30
Cys Ile Pro Cys Ala Asp Phe Pro Ile Phe Thr Cys 
1               5                   10          


<210> 31
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 31
Cys Thr Pro Cys Ala Asp Phe Pro Ile Trp Gly Cys 
1               5                   10          


<210> 32
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 32
Cys Thr Pro Cys Ala Asp Phe Pro Ile Trp Gly Cys 
1               5                   10          


<210> 33
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (13)..(13)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(13)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 33
Cys Asp Phe Thr Met Pro Cys Glu Asn Trp Lys Tyr Cys 
1               5                   10              


<210> 34
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (13)..(13)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(13)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 34
Cys Asp Phe Thr Met Pro Cys Pro Asn Trp Asn Ala Cys 
1               5                   10              


<210> 35
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (13)..(13)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(13)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 35
Cys Asp Phe Thr Met Pro Cys Gln Met Trp Glu Gln Cys 
1               5                   10              


<210> 36
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (13)..(13)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(13)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 36
Cys Ile Phe Asp Tyr Asp Cys Asp Ala Trp Ser Ala Cys 
1               5                   10              


<210> 37
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 37
Cys Phe Trp Leu Asp Gly Glu Cys Phe Asp Trp Asn His Glu Cys 
1               5                   10                  15  


<210> 38
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 38
Cys Phe His Leu Asp Gly Glu Cys Phe Asp Leu Glu Asn Thr Cys 
1               5                   10                  15  


<210> 39
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 39
Cys Phe Trp Leu Asp Gly Glu Cys Phe Asp Trp Asn His Glu Cys 
1               5                   10                  15  


<210> 40
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 40
Cys Phe Trp Leu Asp Gly Glu Cys Phe Asp Trp Asn His Glu Cys 
1               5                   10                  15  


<210> 41
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(9)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 41
Cys Ala Trp Leu Cys Pro Asn Leu Cys 
1               5                   


<210> 42
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 42
Cys Phe Trp Leu Asp Gly Glu Cys Phe Asp Trp Asn His Glu Cys 
1               5                   10                  15  


<210> 43
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 43
Cys Phe Ser Leu Asp Gly Glu Cys Phe Asp Leu Ser Gly Glu Cys 
1               5                   10                  15  


<210> 44
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 44
Cys Phe Thr Leu Asp Gly Glu Cys Phe Asp Trp Thr His Glu Cys 
1               5                   10                  15  


<210> 45
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 45
Cys Phe Lys Leu Asp Gly Val Cys Phe Asp Leu Phe His Glu Cys 
1               5                   10                  15  


<210> 46
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 46
Cys Phe Met Leu Asp Gly Glu Cys Phe Asp Leu Asn Lys Glu Cys 
1               5                   10                  15  


<210> 47
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 47
Cys Phe Lys Leu Asp Gly Glu Cys Phe Asp Trp Thr His Glu Cys 
1               5                   10                  15  


<210> 48
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 48
Cys Phe Thr Leu Asp Gly Glu Cys Phe Asp Trp Asp Ala Glu Cys 
1               5                   10                  15  


<210> 49
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 49
Cys Phe Glu Leu Asp Gly Ser Cys Phe Asp Phe Asp His Glu Cys 
1               5                   10                  15  


<210> 50
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 50
Cys Phe Thr Leu Asp Gly Glu Cys Phe Asp Val Asn Arg Glu Cys 
1               5                   10                  15  


<210> 51
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 51
Cys Phe Trp Leu Asp His Glu Cys Phe Asp Trp Thr His Glu Cys 
1               5                   10                  15  


<210> 52
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 52
Cys Phe Gln Leu Asp Gly Glu Cys Phe Asp Ile Tyr Arg Glu Cys 
1               5                   10                  15  


<210> 53
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 53
Cys Phe Glu Leu Asp Gly Asn Cys Phe Asp Trp Thr His Glu Cys 
1               5                   10                  15  


<210> 54
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 54
Cys Phe His Leu Asp Gly Glu Cys Phe Asp Tyr Glu His Glu Cys 
1               5                   10                  15  


<210> 55
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 55
Cys Phe Ser Leu Asp Gly Glu Cys Phe Asp Ile Ala Ser Glu Cys 
1               5                   10                  15  


<210> 56
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 56
Cys Phe Gln Leu Asp Gly Glu Cys Phe Asp Thr Ser His Glu Cys 
1               5                   10                  15  


<210> 57
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 57
Cys Phe Ser Leu Asp Gly Ala Cys Phe Asp Trp Thr His Glu Cys 
1               5                   10                  15  


<210> 58
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 58
Cys Phe Val Leu Asp Gly Glu Cys Phe Asp Tyr Tyr Glu Glu Cys 
1               5                   10                  15  


<210> 59
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 59
Cys Phe Arg Leu Asp Asp Glu Cys Phe Asp Trp Thr His Glu Cys 
1               5                   10                  15  


<210> 60
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 60
Cys Phe Arg Leu Asp Gly Val Cys Phe Asp Leu Asp Asp Glu Cys 
1               5                   10                  15  


<210> 61
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 61
Cys Phe Arg Leu Asp Gly Glu Cys Phe Asp Met Gly Gln Glu Cys 
1               5                   10                  15  


<210> 62
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 62
Cys Phe Thr Leu Asp Gly Ala Cys Phe Asp Leu Asp Gly Glu Cys 
1               5                   10                  15  


<210> 63
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 63
Cys Phe Thr Leu Asp Gly Gln Cys Phe Asp Trp Thr His Glu Cys 
1               5                   10                  15  


<210> 64
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 64
Cys Phe Leu Leu Asp Gly Glu Cys Phe Asp Trp Met Gln Glu Cys 
1               5                   10                  15  


<210> 65
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 65
Cys Phe Glu Leu Asp Gly Asp Cys Phe Asp Trp Thr His Glu Cys 
1               5                   10                  15  


<210> 66
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 66
Cys Phe Thr Leu Asp Gly Thr Cys Phe Asp Trp Thr His Glu Cys 
1               5                   10                  15  


<210> 67
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 67
Cys Phe His Leu Asp Gly Val Cys Phe Asp Trp Thr His Glu Cys 
1               5                   10                  15  


<210> 68
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 68
Cys Phe Tyr Leu Asp Gly Thr Cys Phe Asp Trp Thr His Glu Cys 
1               5                   10                  15  


<210> 69
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 69
Cys Phe Leu Leu Asp Gly Glu Cys Phe Asp Trp Ala Gln Glu Cys 
1               5                   10                  15  


<210> 70
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 70
Cys Phe His Leu Asp Gly Glu Cys Phe Asp Leu Glu Asn Thr Cys 
1               5                   10                  15  


<210> 71
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 71
Cys Phe His Leu Asp Gly Glu Cys Phe Asp Leu Ala Lys Thr Cys 
1               5                   10                  15  


<210> 72
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 72
Cys Phe Glu Leu Asp Gly Glu Cys Phe His Phe Gly Glu Pro Cys 
1               5                   10                  15  


<210> 73
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 73
Cys Phe Val Leu Asp Gly Glu Cys Phe Glu Ile Gly Glu Arg Cys 
1               5                   10                  15  


<210> 74
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 74
Cys Phe Thr Leu Asp Gly Glu Cys Phe Asp Leu Asp Gly Trp Cys 
1               5                   10                  15  


<210> 75
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 75
Cys Phe Leu Leu Asp Gly Glu Cys Phe Asp Leu Ile Gly Glu Cys 
1               5                   10                  15  


<210> 76
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 76
Cys Phe Glu Leu Asp Gly Glu Cys Phe Ser Phe Pro Gly Thr Cys 
1               5                   10                  15  


<210> 77
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 77
Cys Phe Glu Leu Asp Gly Glu Cys Phe Ser Trp Pro Tyr Pro Cys 
1               5                   10                  15  


<210> 78
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 78
Cys Phe Thr Leu Asp Gly Glu Cys Phe Leu Leu Gly Glu Asn Cys 
1               5                   10                  15  


<210> 79
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 79
Cys Phe Trp Leu Asp Gly Glu Cys Phe Asp Leu Gly Gly Gln Cys 
1               5                   10                  15  


<210> 80
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 80
Cys Phe Glu Leu Asp Gly Glu Cys Phe Asp Leu Asp Asn Gln Cys 
1               5                   10                  15  


<210> 81
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 81
Cys Phe Trp Leu Asp Gly Glu Cys Phe Asp Leu Tyr Gly Gly Cys 
1               5                   10                  15  


<210> 82
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 82
Cys Phe Arg Leu Asp Gly Glu Cys Phe Asp Ile Ser Asn Glu Cys 
1               5                   10                  15  


<210> 83
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 83
Cys Phe Glu Leu Asp Gly Glu Cys Phe Asn Ile Gly Ser Lys Cys 
1               5                   10                  15  


<210> 84
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (14)..(14)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(14)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 84
Cys Phe Trp Leu Asp Gly Glu Cys Phe Asp Phe Gly Gly Cys 
1               5                   10                  


<210> 85
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 85
Cys Phe Thr Leu Asp Gly Ala Cys Phe Asp Trp Thr His Glu Cys 
1               5                   10                  15  


<210> 86
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 86
Cys Asp Tyr Cys Val Arg Leu Gly Leu Thr Gly Cys 
1               5                   10          


<210> 87
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 87
Cys Gly Trp Cys Ser Asp Gln Ile Asp Gly Phe Cys 
1               5                   10          


<210> 88
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 88
Cys Ala Trp Cys Ser Asp Pro Ile Asp Gly Phe Cys 
1               5                   10          


<210> 89
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 89
Cys Asp Trp Cys Ile Asp Pro Gly Val Ser Phe Cys 
1               5                   10          


<210> 90
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 90
Cys Ser Trp Cys Val Asp Asp Gly Leu Pro Phe Cys 
1               5                   10          


<210> 91
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 91
Cys Thr Trp Cys Val Asp Asp Gly Leu Ser Phe Cys 
1               5                   10          


<210> 92
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 92
Cys Thr Trp Cys Val Asp Asp Glu Thr Trp Asn Cys 
1               5                   10          


<210> 93
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 93
Cys Asp Tyr Cys Ile Arg Leu Gly Leu Thr Gly Cys 
1               5                   10          


<210> 94
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 94
Cys Asp Trp Cys Thr Asp Asn Ile Pro Gly Ile Cys 
1               5                   10          


<210> 95
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 95
Cys Ile Arg Tyr Gly Asp Ile Cys Tyr Asp Pro Asp His Ser Cys 
1               5                   10                  15  


<210> 96
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 96
Cys Ile Arg Tyr Gly Asp Ile Cys Phe His Pro Asp Tyr Thr Cys 
1               5                   10                  15  


<210> 97
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 97
Cys Ile Asn Tyr Ala Asn Ile Cys Leu Asp Thr Glu Lys Met Cys 
1               5                   10                  15  


<210> 98
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(9)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 98
Cys Asn Phe Leu Cys Asp Asp Leu Cys 
1               5                   


<210> 99
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 99
Cys Tyr Trp Asn Pro Phe Met Gly Cys Tyr Thr Cys 
1               5                   10          


<210> 100
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 100
Cys Tyr Trp Asn Pro Phe Thr Gly Cys Tyr Ser Cys 
1               5                   10          


<210> 101
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 101
Cys Tyr Trp Asn Pro Phe Ile Gln Cys Ser Pro Cys 
1               5                   10          


<210> 102
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 102
Cys Tyr Trp Asn Pro Phe Thr Ala Cys Tyr Met Cys 
1               5                   10          


<210> 103
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 103
Cys Tyr Trp Asn Pro Phe Thr Ala Cys Tyr Thr Cys 
1               5                   10          


<210> 104
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 104
Cys Tyr Trp Asn Pro Phe Ala Ala Cys Tyr Asp Cys 
1               5                   10          


<210> 105
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 105
Cys Tyr Trp Asn Pro Phe Ser Gly Cys Tyr Ser Cys 
1               5                   10          


<210> 106
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 106
Cys Met Trp Asn Pro Phe Thr Gly Cys Tyr Ala Cys 
1               5                   10          


<210> 107
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 107
Cys Leu Tyr Asn Pro Phe Thr Gly Cys Tyr Asp Cys 
1               5                   10          


<210> 108
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 108
Cys Tyr Trp Asn Pro Phe Ser Gly Cys Trp Asp Cys 
1               5                   10          


<210> 109
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 109
Cys Tyr Trp Asn Pro Phe Met Ala Cys Phe Asp Cys 
1               5                   10          


<210> 110
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 110
Cys Tyr Trp Asn Pro Phe Met Gly Cys Tyr Ser Cys 
1               5                   10          


<210> 111
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 111
Cys Tyr Trp Asn Pro Phe Met Ala Cys Tyr Val Cys 
1               5                   10          


<210> 112
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 112
Cys Tyr Trp Asn Pro Phe Met Gly Cys Tyr Val Cys 
1               5                   10          


<210> 113
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 113
Cys Tyr Trp Asn Pro Phe Thr Gly Cys Tyr Ala Cys 
1               5                   10          


<210> 114
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 114
Cys Tyr Trp Asn Pro Phe Thr Gly Cys Tyr Ala Cys 
1               5                   10          


<210> 115
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 115
Cys Tyr Trp Asn Pro Phe Thr Ala Cys Trp Ser Cys 
1               5                   10          


<210> 116
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 116
Cys Phe Trp Asn Pro Phe Thr Gly Cys Tyr Ser Cys 
1               5                   10          


<210> 117
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 117
Cys Phe Trp Asn Pro Phe Thr Gly Cys Tyr Ser Cys 
1               5                   10          


<210> 118
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 118
Cys Tyr Trp Asn Pro Phe Thr Ala Cys Phe Ser Cys 
1               5                   10          


<210> 119
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 119
Cys Tyr Trp Asn Pro Phe Thr Ala Cys Tyr Val Cys 
1               5                   10          


<210> 120
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 120
Cys Tyr Trp Asn Pro Phe Thr Ala Cys Tyr Ser Cys 
1               5                   10          


<210> 121
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 121
Cys Tyr Trp Asn Pro Phe Thr Ala Cys Trp Ala Cys 
1               5                   10          


<210> 122
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 122
Cys Tyr Trp Asn Pro Phe Thr Ala Cys Phe Ala Cys 
1               5                   10          


<210> 123
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 123
Cys Tyr Trp Asn Pro Phe Thr Ala Cys Trp Ser Cys 
1               5                   10          


<210> 124
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> MOD_RES
<222> (3)..(3)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (6)..(7)
<223> Any amino acid

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> MOD_RES
<222> (11)..(13)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Any amino acid or absent

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 124
Cys Phe Xaa Leu Asp Xaa Xaa Cys Phe Asp Xaa Xaa Xaa Xaa Cys 
1               5                   10                  15  


<210> 125
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="Asn"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Ala"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="Asn"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any amino acid

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="His"

<220>
<221> VARIANT
<222> (11)..(11)
<223> /replace="Thr"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Glu"

<220>
<221> MOD_RES
<222> (13)..(14)
<223> Any amino acid

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 125
Cys Ile Arg Tyr Gly Asp Ile Cys Xaa Asp Pro Asp Xaa Xaa Cys 
1               5                   10                  15  


<210> 126
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> MOD_RES
<222> (3)..(3)
<223> Any amino acid

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> MOD_RES
<222> (10)..(11)
<223> Any amino acid

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Pro"

<220>
<221> MOD_RES
<222> (13)..(14)
<223> Any amino acid

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 126
Cys Phe Xaa Leu Asp Gly Glu Cys Phe Xaa Xaa Gly Xaa Xaa Cys 
1               5                   10                  15  


<210> 127
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> MOD_RES
<222> (2)..(3)
<223> Any amino acid

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="Met"

<220>
<221> MOD_RES
<222> (10)..(11)
<223> Any amino acid

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 127
Cys Xaa Xaa Cys Ala Asp Phe Pro Ile Xaa Xaa Cys 
1               5                   10          


<210> 128

<400> 128
000


<210> 129
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any amino acid

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="Tyr"

<220>
<221> MOD_RES
<222> (7)..(8)
<223> Any amino acid

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> MOD_RES
<222> (10)..(11)
<223> Any amino acid

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 129
Cys Xaa Trp Asn Pro Phe Xaa Xaa Cys Xaa Xaa Cys 
1               5                   10          


<210> 130

<400> 130
000


<210> 131
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Asn" 

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="Phe" 

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="Asp" 

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="Asp" 

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(9)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 131
Cys Ala Trp Leu Cys Pro Asn Leu Cys 
1               5                   


<210> 132
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> MOD_RES
<222> (8)..(9)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (11)..(12)
<223> Any amino acid

<220>
<221> VARIANT
<222> (13)..(13)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(13)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 132
Cys Asp Phe Thr Met Pro Cys Xaa Xaa Trp Xaa Xaa Cys 
1               5                   10              


<210> 133
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Beta-Ala

<220>
<221> MOD_RES
<222> (2)..(11)
<223> Sarcosine

<400> 133
Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Ala 
1               5                   10          


<210> 134
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> VARIANT
<222> (13)..(13)
<223> /replace="Dap" or "N-AlkDap" or "N-HAlkDap"

<220>
<221> SITE
<222> (1)..(13)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 134
Cys Leu Asp His Met Glu Cys Arg Gly Asp Met Asp Cys 
1               5                   10              


<210> 135
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (2)..(11)
<223> Sarcosine

<400> 135
Gly Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Ala 
1               5                   10          


<210> 136
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (15)..(20)
<223> Sarcosine

<400> 136
Ala Cys Thr Pro Cys Ala Asp Phe Pro Ile Trp Gly Cys Ala Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Lys 
            20      


<210> 137
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (15)..(20)
<223> Sarcosine

<400> 137
Ala Cys Tyr Trp Asn Pro Phe Thr Gly Cys Tyr Thr Cys Ala Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Lys 
            20      


<210> 138
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 138
Ala Cys Val Pro Cys Ala Asp Phe Pro Ile Trp Tyr Cys 
1               5                   10              


<210> 139
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (2)..(7)
<223> Sarcosine

<400> 139
Ala Xaa Xaa Xaa Xaa Xaa Xaa Lys 
1               5               


<210> 140
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (2)..(7)
<223> Sarcosine

<400> 140
Ala Xaa Xaa Xaa Xaa Xaa Xaa Lys 
1               5               


<210> 141
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (2)..(7)
<223> Sarcosine

<400> 141
Ala Xaa Xaa Xaa Xaa Xaa Xaa Lys 
1               5               


<210> 142
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 142
Ala Cys Tyr Trp Asn Pro Phe Thr Ala Cys Trp Ser Cys Asp Thr Ser 
1               5                   10                  15      


<210> 143
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Beta-Ala

<220>
<221> MOD_RES
<222> (2)..(11)
<223> Sarcosine 

<400> 143
Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Ala 
1               5                   10          


<210> 144
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (2)..(7)
<223> Sarcosine 

<400> 144
Ala Xaa Xaa Xaa Xaa Xaa Xaa 
1               5           


<210> 145
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 145
Ala Ser Asp Asn 
1               


<210> 146
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 146
Ala Arg Asn Glu 
1               


<210> 147
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 147
Phe Ser Cys Asp Asp Asp 
1               5       


<210> 148
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 148
Ser Ser Gln His Gly 
1               5   


<210> 149
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 149
Ala Cys Tyr Trp Asn Pro Phe Thr Ala Cys Phe Ala Cys Glu Glu Pro 
1               5                   10                  15      


<210> 150
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 150
Arg His Ser Asn Tyr 
1               5   


<210> 151
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (2)..(2)
<223> N-methyl Dap

<400> 151
Ala Xaa Val Pro Cys Ala Asp Phe Pro Ile Trp Tyr Cys 
1               5                   10              


<210> 152
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (5)..(5)
<223> N-methyl Dap

<400> 152
Ala Cys Val Pro Xaa Ala Asp Phe Pro Ile Trp Tyr Cys 
1               5                   10              


<210> 153
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (13)..(13)
<223> N-methyl Dap

<400> 153
Ala Cys Val Pro Cys Ala Asp Phe Pro Ile Trp Tyr Xaa 
1               5                   10              


<210> 154
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (2)..(2)
<223> N-methyl Dap

<220>
<221> MOD_RES
<222> (5)..(5)
<223> N-methyl Dap

<400> 154
Ala Xaa Val Pro Xaa Ala Asp Phe Pro Ile Trp Tyr Cys 
1               5                   10              


<210> 155
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (5)..(5)
<223> N-methyl Dap

<220>
<221> MOD_RES
<222> (13)..(13)
<223> N-methyl Dap

<400> 155
Ala Cys Val Pro Xaa Ala Asp Phe Pro Ile Trp Tyr Xaa 
1               5                   10              


<210> 156
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (2)..(2)
<223> N-methyl Dap

<220>
<221> MOD_RES
<222> (13)..(13)
<223> N-methyl Dap

<400> 156
Ala Xaa Val Pro Cys Ala Asp Phe Pro Ile Trp Tyr Xaa 
1               5                   10              


<210> 157
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (2)..(2)
<223> N-methyl Dap

<220>
<221> MOD_RES
<222> (5)..(5)
<223> N-methyl Dap

<220>
<221> MOD_RES
<222> (13)..(13)
<223> N-methyl Dap

<400> 157
Ala Xaa Val Pro Xaa Ala Asp Phe Pro Ile Trp Tyr Xaa 
1               5                   10              


<210> 158
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 158
Ala Cys Phe Glu Leu Asp Gly Thr Cys Phe Asp Trp Ala Gln Glu Cys 
1               5                   10                  15      


Ala 
    


<210> 159
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 159
Ala Cys Val Asn Phe Gly Ser Val Cys Trp Asp Pro Asp Ser Arg Cys 
1               5                   10                  15      


Ala 
    


<210> 160
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 160
Ala Cys Val Pro Cys Ala Asp Phe Pro Ile Trp Tyr Cys Ala 
1               5                   10                  


<210> 161
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 161
Ala Cys Val Pro Cys Ala Asp Phe Pro Ile Trp Trp Cys Ala 
1               5                   10                  


<210> 162
<211> 24
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Beta-Ala

<220>
<221> MOD_RES
<222> (2)..(11)
<223> Sarcosine 

<400> 162
Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Ala Cys Val Pro Cys 
1               5                   10                  15      


Ala Asp Phe Pro Ile Trp Tyr Cys 
            20                  


<210> 163
<211> 24
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Beta-Ala

<220>
<221> MOD_RES
<222> (2)..(11)
<223> Sarcosine 

<400> 163
Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Ala Cys Val Pro Cys 
1               5                   10                  15      


Ala Asp Phe Pro Ile Trp Tyr Cys 
            20                  


<210> 164
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (14)..(19)
<223> Sarcosine 

<400> 164
Cys Val Pro Cys Ala Asp Phe Pro Ile Trp Tyr Cys Ala Xaa Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Lys 
            20  


<210> 165
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (14)..(19)
<223> Sarcosine 

<400> 165
Cys Val Pro Cys Ala Asp Phe Pro Ile Trp Tyr Cys Ala Xaa Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa 
            


<210> 166
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 166
Ala Cys Thr Pro Cys Ala Asp Phe Pro Ile Trp Ser Cys Ala 
1               5                   10                  


<210> 167
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 167
Ala Cys Thr Pro Cys Ala Asp Phe Pro Ile His Thr Cys Ala 
1               5                   10                  


<210> 168
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 168
Ala Cys Val His Cys Ala Asp Phe Pro Ile Trp Gly Cys Ala 
1               5                   10                  


<210> 169
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 169
Ala Cys Val Pro Cys Ala Asp Phe Pro Ile Trp Gly Cys Ala 
1               5                   10                  


<210> 170
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 170
Cys Val Pro Cys Ala Asp Phe Pro Ile Trp Gly Cys 
1               5                   10          


<210> 171
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 171
Ala Cys Val Met Cys Ala Asp Phe Pro Ile Trp Gly Cys Ala 
1               5                   10                  


<210> 172
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 172
Ala Cys Thr Pro Cys Ala Asp Phe Pro Ile Trp Tyr Cys Ala 
1               5                   10                  


<210> 173
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 173
Cys Thr Pro Cys Ala Asp Phe Pro Ile Trp Tyr Cys 
1               5                   10          


<210> 174
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 174
Ala Cys Thr Pro Cys Ala Asp Phe Pro Ile Leu Thr Cys Ala 
1               5                   10                  


<210> 175
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 175
Ala Cys Val Ala Cys Ala Asp Phe Pro Ile Trp Gly Cys Ala 
1               5                   10                  


<210> 176
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 176
Ala Cys Thr Pro Cys Ala Asp Phe Pro Ile Tyr Gly Cys Ala 
1               5                   10                  


<210> 177
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 177
Ala Cys Thr Pro Cys Ala Asp Phe Pro Ile Leu Asp Cys Ala 
1               5                   10                  


<210> 178
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 178
Ala Cys Val Lys Cys Ala Asp Phe Pro Ile Trp Gly Cys Ala 
1               5                   10                  


<210> 179
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 179
Cys Val Lys Cys Ala Asp Phe Pro Ile Trp Gly Cys 
1               5                   10          


<210> 180
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 180
Ala Cys Thr Pro Cys Ala Asp Met Pro Ile Trp Thr Cys Ala 
1               5                   10                  


<210> 181
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 181
Ala Cys Ile Pro Cys Ala Asp Phe Pro Ile Trp Gly Cys Ala 
1               5                   10                  


<210> 182
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 182
Ala Cys Ile Pro Cys Ala Asp Phe Pro Ile Ser Val Cys Ala 
1               5                   10                  


<210> 183
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 183
Ala Cys Val Pro Cys Ala Asp Phe Pro Ile Ser Phe Cys Ala 
1               5                   10                  


<210> 184
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 184
Ala Cys Ile Pro Cys Ala Asp Phe Pro Ile Ser Phe Cys Ala 
1               5                   10                  


<210> 185
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 185
Ala Cys Val Pro Cys Ala Asp Phe Pro Ile Ser Val Cys Ala 
1               5                   10                  


<210> 186
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 186
Ala Cys Val Pro Cys Ala Asp Phe Pro Ile Phe Thr Cys Ala 
1               5                   10                  


<210> 187
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 187
Ala Cys Ile Pro Cys Ala Asp Phe Pro Ile Phe Thr Cys Ala 
1               5                   10                  


<210> 188
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 188
Ala Cys Thr Pro Cys Ala Asp Phe Pro Ile Trp Gly Cys Ala 
1               5                   10                  


<210> 189
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (15)..(20)
<223> Sarcosine 

<400> 189
Ala Cys Thr Pro Cys Ala Asp Phe Pro Ile Trp Gly Cys Ala Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Lys 
            20      


<210> 190
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 190
Ala Cys Asp Phe Thr Met Pro Cys Glu Asn Trp Lys Tyr Cys Ala 
1               5                   10                  15  


<210> 191
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 191
Ala Cys Asp Phe Thr Met Pro Cys Pro Asn Trp Asn Ala Cys Ala 
1               5                   10                  15  


<210> 192
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 192
Ala Cys Asp Phe Thr Met Pro Cys Gln Met Trp Glu Gln Cys Ala 
1               5                   10                  15  


<210> 193
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 193
Ala Cys Ile Phe Asp Tyr Asp Cys Asp Ala Trp Ser Ala Cys Ala 
1               5                   10                  15  


<210> 194
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 194
Ala Cys Phe Trp Leu Asp Gly Glu Cys Phe Asp Trp Asn His Glu Cys 
1               5                   10                  15      


Ala 
    


<210> 195
<211> 24
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (18)..(23)
<223> Sarcosine 

<400> 195
Ala Cys Phe His Leu Asp Gly Glu Cys Phe Asp Leu Glu Asn Thr Cys 
1               5                   10                  15      


Ala Xaa Xaa Xaa Xaa Xaa Xaa Lys 
            20                  


<210> 196
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 196
Cys Phe Trp Leu Asp Gly Glu Cys Phe Asp Trp Asn His Glu Cys 
1               5                   10                  15  


<210> 197
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (17)..(22)
<223> Sarcosine 

<400> 197
Cys Phe Trp Leu Asp Gly Glu Cys Phe Asp Trp Asn His Glu Cys Ala 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Xaa Xaa Lys 
            20              


<210> 198
<211> 22
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (16)..(21)
<223> Sarcosine 

<400> 198
Ser Ser Gln His Gly Cys Ala Trp Leu Cys Pro Asn Leu Cys Ala Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Xaa Lys 
            20          


<210> 199
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (17)..(22)
<223> Sarcosine 

<400> 199
Cys Phe Trp Leu Asp Gly Glu Cys Phe Asp Trp Asn His Glu Cys Ala 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Xaa Xaa Lys 
            20              


<210> 200
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 200
Ala Cys Phe Ser Leu Asp Gly Glu Cys Phe Asp Leu Ser Gly Glu Cys 
1               5                   10                  15      


Ala 
    


<210> 201
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 201
Ala Cys Phe Thr Leu Asp Gly Glu Cys Phe Asp Trp Thr His Glu Cys 
1               5                   10                  15      


Ala 
    


<210> 202
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 202
Ala Cys Phe Lys Leu Asp Gly Val Cys Phe Asp Leu Phe His Glu Cys 
1               5                   10                  15      


Ala 
    


<210> 203
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 203
Ala Cys Phe Met Leu Asp Gly Glu Cys Phe Asp Leu Asn Lys Glu Cys 
1               5                   10                  15      


Ala 
    


<210> 204
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 204
Ala Cys Phe Lys Leu Asp Gly Glu Cys Phe Asp Trp Thr His Glu Cys 
1               5                   10                  15      


Ala 
    


<210> 205
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 205
Ala Cys Phe Thr Leu Asp Gly Glu Cys Phe Asp Trp Asp Ala Glu Cys 
1               5                   10                  15      


Ala 
    


<210> 206
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 206
Ala Cys Phe Glu Leu Asp Gly Ser Cys Phe Asp Phe Asp His Glu Cys 
1               5                   10                  15      


Ala 
    


<210> 207
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 207
Ala Cys Phe Thr Leu Asp Gly Glu Cys Phe Asp Val Asn Arg Glu Cys 
1               5                   10                  15      


Ala 
    


<210> 208
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 208
Ala Cys Phe Trp Leu Asp His Glu Cys Phe Asp Trp Thr His Glu Cys 
1               5                   10                  15      


Ala 
    


<210> 209
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 209
Ala Cys Phe Gln Leu Asp Gly Glu Cys Phe Asp Ile Tyr Arg Glu Cys 
1               5                   10                  15      


Ala 
    


<210> 210
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 210
Ala Cys Phe Glu Leu Asp Gly Asn Cys Phe Asp Trp Thr His Glu Cys 
1               5                   10                  15      


Ala 
    


<210> 211
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 211
Ala Cys Phe His Leu Asp Gly Glu Cys Phe Asp Tyr Glu His Glu Cys 
1               5                   10                  15      


Ala 
    


<210> 212
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 212
Ala Cys Phe Ser Leu Asp Gly Glu Cys Phe Asp Ile Ala Ser Glu Cys 
1               5                   10                  15      


Ala 
    


<210> 213
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 213
Ala Cys Phe Gln Leu Asp Gly Glu Cys Phe Asp Thr Ser His Glu Cys 
1               5                   10                  15      


Ala 
    


<210> 214
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 214
Ala Cys Phe Ser Leu Asp Gly Ala Cys Phe Asp Trp Thr His Glu Cys 
1               5                   10                  15      


Ala 
    


<210> 215
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 215
Ala Cys Phe Val Leu Asp Gly Glu Cys Phe Asp Tyr Tyr Glu Glu Cys 
1               5                   10                  15      


Ala 
    


<210> 216
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 216
Ala Cys Phe Arg Leu Asp Asp Glu Cys Phe Asp Trp Thr His Glu Cys 
1               5                   10                  15      


Ala 
    


<210> 217
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 217
Ala Cys Phe Arg Leu Asp Gly Val Cys Phe Asp Leu Asp Asp Glu Cys 
1               5                   10                  15      


Ala 
    


<210> 218
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 218
Ala Cys Phe Arg Leu Asp Gly Glu Cys Phe Asp Met Gly Gln Glu Cys 
1               5                   10                  15      


Ala 
    


<210> 219
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 219
Ala Cys Phe Thr Leu Asp Gly Ala Cys Phe Asp Leu Asp Gly Glu Cys 
1               5                   10                  15      


Ala 
    


<210> 220
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 220
Ala Cys Phe Thr Leu Asp Gly Gln Cys Phe Asp Trp Thr His Glu Cys 
1               5                   10                  15      


Ala 
    


<210> 221
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 221
Ala Cys Phe Leu Leu Asp Gly Glu Cys Phe Asp Trp Met Gln Glu Cys 
1               5                   10                  15      


Ala 
    


<210> 222
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 222
Ala Cys Phe Glu Leu Asp Gly Asp Cys Phe Asp Trp Thr His Glu Cys 
1               5                   10                  15      


Ala 
    


<210> 223
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 223
Ala Cys Phe Thr Leu Asp Gly Thr Cys Phe Asp Trp Thr His Glu Cys 
1               5                   10                  15      


Ala 
    


<210> 224
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 224
Ala Cys Phe His Leu Asp Gly Val Cys Phe Asp Trp Thr His Glu Cys 
1               5                   10                  15      


Ala 
    


<210> 225
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 225
Ala Cys Phe Tyr Leu Asp Gly Thr Cys Phe Asp Trp Thr His Glu Cys 
1               5                   10                  15      


Ala 
    


<210> 226
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 226
Ala Cys Phe Leu Leu Asp Gly Glu Cys Phe Asp Trp Ala Gln Glu Cys 
1               5                   10                  15      


Ala 
    


<210> 227
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 227
Ala Cys Phe His Leu Asp Gly Glu Cys Phe Asp Leu Glu Asn Thr Cys 
1               5                   10                  15      


Ala 
    


<210> 228
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 228
Ala Cys Phe His Leu Asp Gly Glu Cys Phe Asp Leu Ala Lys Thr Cys 
1               5                   10                  15      


Ala 
    


<210> 229
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 229
Ala Cys Phe Glu Leu Asp Gly Glu Cys Phe His Phe Gly Glu Pro Cys 
1               5                   10                  15      


Ala 
    


<210> 230
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 230
Ala Cys Phe Val Leu Asp Gly Glu Cys Phe Glu Ile Gly Glu Arg Cys 
1               5                   10                  15      


Ala 
    


<210> 231
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 231
Ala Cys Phe Thr Leu Asp Gly Glu Cys Phe Asp Leu Asp Gly Trp Cys 
1               5                   10                  15      


Ala 
    


<210> 232
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 232
Ala Cys Phe Leu Leu Asp Gly Glu Cys Phe Asp Leu Ile Gly Glu Cys 
1               5                   10                  15      


Ala 
    


<210> 233
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 233
Ala Cys Phe Glu Leu Asp Gly Glu Cys Phe Ser Phe Pro Gly Thr Cys 
1               5                   10                  15      


Ala 
    


<210> 234
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 234
Ala Cys Phe Glu Leu Asp Gly Glu Cys Phe Ser Trp Pro Tyr Pro Cys 
1               5                   10                  15      


Ala 
    


<210> 235
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 235
Ala Cys Phe Thr Leu Asp Gly Glu Cys Phe Leu Leu Gly Glu Asn Cys 
1               5                   10                  15      


Ala 
    


<210> 236
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 236
Ala Cys Phe Trp Leu Asp Gly Glu Cys Phe Asp Leu Gly Gly Gln Cys 
1               5                   10                  15      


Ala 
    


<210> 237
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 237
Ala Cys Phe Glu Leu Asp Gly Glu Cys Phe Asp Leu Asp Asn Gln Cys 
1               5                   10                  15      


Ala 
    


<210> 238
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 238
Ala Cys Phe Trp Leu Asp Gly Glu Cys Phe Asp Leu Tyr Gly Gly Cys 
1               5                   10                  15      


Ala 
    


<210> 239
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 239
Ala Cys Phe Arg Leu Asp Gly Glu Cys Phe Asp Ile Ser Asn Glu Cys 
1               5                   10                  15      


Ala 
    


<210> 240
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 240
Ala Cys Phe Glu Leu Asp Gly Glu Cys Phe Asn Ile Gly Ser Lys Cys 
1               5                   10                  15      


Ala 
    


<210> 241
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 241
Ala Cys Phe Trp Leu Asp Gly Glu Cys Phe Asp Phe Gly Gly Cys Ala 
1               5                   10                  15      


<210> 242
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 242
Ala Cys Phe Thr Leu Asp Gly Ala Cys Phe Asp Trp Thr His Glu Cys 
1               5                   10                  15      


Ala 
    


<210> 243
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 243
Ala Cys Asp Tyr Cys Val Arg Leu Gly Leu Thr Gly Cys Ala 
1               5                   10                  


<210> 244
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (15)..(20)
<223> Sarcosine 

<400> 244
Ala Cys Gly Trp Cys Ser Asp Gln Ile Asp Gly Phe Cys Ala Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Lys 
            20      


<210> 245
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (15)..(20)
<223> Sarcosine 

<400> 245
Ala Cys Ala Trp Cys Ser Asp Pro Ile Asp Gly Phe Cys Ala Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Lys 
            20      


<210> 246
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (15)..(20)
<223> Sarcosine 

<400> 246
Ala Cys Asp Trp Cys Ile Asp Pro Gly Val Ser Phe Cys Ala Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Lys 
            20      


<210> 247
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (15)..(20)
<223> Sarcosine 

<400> 247
Ala Cys Ser Trp Cys Val Asp Asp Gly Leu Pro Phe Cys Ala Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Lys 
            20      


<210> 248
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 248
Ala Cys Thr Trp Cys Val Asp Asp Gly Leu Ser Phe Cys Ala 
1               5                   10                  


<210> 249
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 249
Ala Cys Thr Trp Cys Val Asp Asp Glu Thr Trp Asn Cys Ala 
1               5                   10                  


<210> 250
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 250
Ala Cys Asp Tyr Cys Ile Arg Leu Gly Leu Thr Gly Cys Ala 
1               5                   10                  


<210> 251
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 251
Ala Cys Asp Trp Cys Thr Asp Asn Ile Pro Gly Ile Cys Ala 
1               5                   10                  


<210> 252
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 252
Ala Cys Ile Arg Tyr Gly Asp Ile Cys Tyr Asp Pro Asp His Ser Cys 
1               5                   10                  15      


Ala 
    


<210> 253
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 253
Ala Cys Ile Arg Tyr Gly Asp Ile Cys Phe His Pro Asp Tyr Thr Cys 
1               5                   10                  15      


Ala 
    


<210> 254
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 254
Ala Cys Ile Asn Tyr Ala Asn Ile Cys Leu Asp Thr Glu Lys Met Cys 
1               5                   10                  15      


Ala 
    


<210> 255
<211> 22
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (16)..(21)
<223> Sarcosine 

<400> 255
Arg His Ser Asn Tyr Cys Asn Phe Leu Cys Asp Asp Leu Cys Ala Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Xaa Lys 
            20          


<210> 256
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 256
Ala Cys Tyr Trp Asn Pro Phe Met Gly Cys Tyr Thr Cys Ala 
1               5                   10                  


<210> 257
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 257
Ala Cys Tyr Trp Asn Pro Phe Thr Gly Cys Tyr Ser Cys Ala 
1               5                   10                  


<210> 258
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 258
Ala Cys Tyr Trp Asn Pro Phe Ile Gln Cys Ser Pro Cys Ala 
1               5                   10                  


<210> 259
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 259
Ala Cys Tyr Trp Asn Pro Phe Thr Ala Cys Tyr Met Cys Ala 
1               5                   10                  


<210> 260
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 260
Ala Cys Tyr Trp Asn Pro Phe Thr Ala Cys Tyr Thr Cys Ala 
1               5                   10                  


<210> 261
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 261
Ala Cys Tyr Trp Asn Pro Phe Ala Ala Cys Tyr Asp Cys Ala 
1               5                   10                  


<210> 262
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 262
Ala Cys Tyr Trp Asn Pro Phe Ser Gly Cys Tyr Ser Cys Ala 
1               5                   10                  


<210> 263
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 263
Ala Cys Met Trp Asn Pro Phe Thr Gly Cys Tyr Ala Cys Ala 
1               5                   10                  


<210> 264
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 264
Ala Cys Leu Tyr Asn Pro Phe Thr Gly Cys Tyr Asp Cys Ala 
1               5                   10                  


<210> 265
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 265
Ala Cys Tyr Trp Asn Pro Phe Ser Gly Cys Trp Asp Cys Ala 
1               5                   10                  


<210> 266
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 266
Ala Cys Tyr Trp Asn Pro Phe Met Ala Cys Phe Asp Cys Ala 
1               5                   10                  


<210> 267
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 267
Ala Cys Tyr Trp Asn Pro Phe Met Gly Cys Tyr Ser Cys Ala 
1               5                   10                  


<210> 268
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 268
Ala Cys Tyr Trp Asn Pro Phe Met Ala Cys Tyr Val Cys Ala 
1               5                   10                  


<210> 269
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 269
Ala Cys Tyr Trp Asn Pro Phe Met Gly Cys Tyr Val Cys Ala 
1               5                   10                  


<210> 270
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 270
Ala Cys Tyr Trp Asn Pro Phe Thr Gly Cys Tyr Ala Cys Asp Ser Thr 
1               5                   10                  15      


<210> 271
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 271
Ala Cys Tyr Trp Asn Pro Phe Thr Gly Cys Tyr Ala Cys Glu Ala Asp 
1               5                   10                  15      


<210> 272
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 272
Ala Cys Tyr Trp Asn Pro Phe Thr Ala Cys Trp Ser Cys Glu Asn Asp 
1               5                   10                  15      


<210> 273
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 273
Ala Ser Asp Asn Cys Phe Trp Asn Pro Phe Thr Gly Cys Tyr Ser Cys 
1               5                   10                  15      


Ala 
    


<210> 274
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 274
Ala Arg Asn Glu Cys Phe Trp Asn Pro Phe Thr Gly Cys Tyr Ser Cys 
1               5                   10                  15      


Ala 
    


<210> 275
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 275
Ala Cys Tyr Trp Asn Pro Phe Thr Ala Cys Phe Ser Cys Asp Asp Asp 
1               5                   10                  15      


<210> 276
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 276
Ala Cys Tyr Trp Asn Pro Phe Thr Ala Cys Tyr Val Cys Asp Val Pro 
1               5                   10                  15      


<210> 277
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 277
Ala Cys Tyr Trp Asn Pro Phe Thr Ala Cys Tyr Ser Cys Thr Glu Asn 
1               5                   10                  15      


<210> 278
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 278
Ala Cys Tyr Trp Asn Pro Phe Thr Ala Cys Trp Ala Cys Glu Pro Asp 
1               5                   10                  15      


<210> 279
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 279
Ala Cys Val Pro Cys Ala Asp Phe Pro Ile Trp Tyr Cys Ala 
1               5                   10                  


<210> 280
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (2)..(2)
<223> Dap

<400> 280
Ala Xaa Val Pro Cys Ala Asp Phe Pro Ile Trp Tyr Cys Ala 
1               5                   10                  


<210> 281
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (5)..(5)
<223> Dap

<400> 281
Ala Cys Val Pro Xaa Ala Asp Phe Pro Ile Trp Tyr Cys Ala 
1               5                   10                  


<210> 282
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (13)..(13)
<223> Dap

<400> 282
Ala Cys Val Pro Cys Ala Asp Phe Pro Ile Trp Tyr Xaa Ala 
1               5                   10                  


<210> 283
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (2)..(2)
<223> Dap

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Dap

<400> 283
Ala Xaa Val Pro Xaa Ala Asp Phe Pro Ile Trp Tyr Cys Ala 
1               5                   10                  


<210> 284
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (5)..(5)
<223> Dap

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Dap

<400> 284
Ala Cys Val Pro Xaa Ala Asp Phe Pro Ile Trp Tyr Xaa Ala 
1               5                   10                  


<210> 285
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (2)..(2)
<223> Dap

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Dap

<400> 285
Ala Xaa Val Pro Cys Ala Asp Phe Pro Ile Trp Tyr Xaa Ala 
1               5                   10                  


<210> 286
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (2)..(2)
<223> Dap

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Dap

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Dap

<400> 286
Ala Xaa Val Pro Xaa Ala Asp Phe Pro Ile Trp Tyr Xaa Ala 
1               5                   10                  




